Health Translation Queensland

The BDHP Brisbane Cancer Conference is held annually in December at the Brisbane Convention & Exhibition Centre. It draws together cancer researchers in Brisbane and Queensland to advance collaborative efforts in cancer research.[9] The meeting comprises plenary lectures and workshops on recent scientific, technological, nursing and medical advances in the diagnosis and treatment of malignant disease. The BDHP Brisbane Cancer Conference is convened by Professor Ken O’Byrne, Clinical Director of the Cancer and Ageing Research Program.[10][11]

The BDHP Blood Cancers Group Seminar Series is held once a month, alternating between the Translational Research Institute on the Princess Alexandra Hospital campus and the QIMR Berghofer Medical Research Institute on the Royal Brisbane and Women's Hospital campus. Presentations are given by local, national and international researchers, providing an opportunity to hear about the latest research and encourage greater collaboration within and between research streams.[12] The series is convened by Professor Andrew Perkins, Co-leader of the Blood and Bone Diseases Program, Mater Research Institute – University of Queensland.

The BDHP Circulating Tumour Cell Symposium was a single day event that provided up to date coverage of many aspects of tumour research. The event was co-convened by Professor Colleen Nelson, Executive Director of the Australian Prostate Cancer Research Centre-Queensland, and Professor Rik Thompson, of Queensland University of Technology's Institute of Health and Biomedical Innovation. The symposium was attended by some 130 delegates from Queensland University of Technology, The University of Queensland and Griffith Universities, affiliated research institutes, Qld Health, industry and consumer advocacy group representatives, as well as attendees from Victoria, New South Wales, Western Australia and South Australia.[13]